INFLIXIMAB
infliximab 120 mg/mL injection, 1 mL syringe
INFLIXIMAB (12550M)
12550M
Manner of administration:Injection
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Balance of supply for Initial treatment - subcutaneous form
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $760.24 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Remsima SC | |||||